Adial Pharmaceuticals, Inc. ADIL
NASDAQ · United States · Health Technology
$4.13+0.12 (+2.99%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-17 | -11.25 | -1.03 | -989.6% | $0 | — | +36.9%$3.98→$5.45 |
| Q1 2026 | 2026-05-08 | -1.48 | -2.25 | +34.2% | — | — | +1.4%$1.42→$1.44 |
| Q4 2025 | 2026-03-05 | -11.48 | -2.13 | -439.0% | — | — | -8.0%$1.99→$1.83 |
| Q4 2024 | 2025-03-04 | -3.75 | -8.25 | +54.5% | — | — | — |
| Q4 2023 | 2024-04-01 | -9.25 | -19.00 | +51.3% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.